AB0483 CAN WE PREDICT WHICH PATIENTS WITH SPONDYLOARTHRITIS WILL NEED DOSE ESCALATION OF SECUKINUMAB TO 300 mg MONTHLY?

Fonseca, D. ; Oliveira Pinheiro, F. ; Rato, M. ; Fernandes, B. M. ; Garcia, S. ; Martins, A. ; Santos Oliveira, D. ; Martins, F. R. ; Bernardes, M. ; Costa, L.

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1269-1269 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível